| Literature DB >> 36233831 |
Zofia Frajkova1,2,3, Dimitrios Paouris4, Ladislav Nado5, Ivana Vyrvova4, Adelaida Fabianova6, Athanasia Printza7, Lukas Varga1,8, Miroslav Tedla1,9.
Abstract
INTRODUCTION: The objective of the study was the language adaptation and verification of psychometric properties of the Slovak version of the EAT10® questionnaire.Entities:
Keywords: EAT10®; Slovakia; eating; oropharyngeal dysphagia; psychometric properties; subjective assessment; swallowing disorders
Year: 2022 PMID: 36233831 PMCID: PMC9570619 DOI: 10.3390/jcm11195966
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
The Slovak version of the Eating Assessment Tool (Slovak EAT10®).
| Item | Original Version | Slovak Version |
|---|---|---|
| 1 | My swallowing problem has caused me to lose weight. | Kvôli mojim problémom s prehĺtaním som schudol/la. |
| 2 | My swallowing problem interferes with my ability to go out for meals. | Pre problémy s prehĺtaním nemôžem chodiť jesť do spoločnosti. |
| 3 | Swallowing liquids takes extra effort. | Prehĺtanie tekutín je pre mňa namáhavé. |
| 4 | Swallowing solids takes extra effort. | Prehĺtanie tuhej stravy je pre mňa namáhavé. |
| 5 | Swallowing pills takes extra effort. | Prehĺtanie tabliet je pre mňa namáhavé. |
| 6 | Swallowing is painful. | Prehĺtanie je bolestivé. |
| 7 | The pleasure of eating is affected by my swallowing. | Prehĺtanie ovplyvňuje môj pôžitok z jedla. |
| 8 | When I swallow food sticks in my throat. | Pri prehĺtaní sa mi jedlo zasekne v hrdle. |
| 9 | I cough when I eat. | Pri jedle kašlem. |
| 10 | Swallowing is stressful. | Prehĺtanie je pre mňa stresujúce. |
The demographic and clinical characteristics of the participants.
| Variable | Value | Control Group | Dysphagic Group | Total | |||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | ||
| Gender | Female | 67 | 49.3 | 17 | 33.3 | 84 | 44.9 |
| Male | 69 | 50.7 | 34 | 66.7 | 103 | 55.1 | |
| Age | Mean ± SD | 56.68 ± 13.74 | 58.02 ± 16.78 | 57.05 ± 14.6 | |||
| Median | 56 | 60 | 58 | ||||
| Min | 20 | 20 | 20 | ||||
| Max | 81 | 91 | 91 | ||||
| BMI | Mean ± SD | 26.75 ± 4.89 | 24.69 ± 5.28 | 26.19 ± 5.07 | |||
| Median | 26.3 | 23.27 | 25.5 | ||||
| Min | 17.47 | 15.42 | 15.42 | ||||
| Max | 45.91 | 43.15 | 45.91 | ||||
| Diagnosis | HNC | - | - | 12 | 23.5 | ||
| Esophageal | - | - | 8 | 15.7 | |||
| Iatrogenic | - | - | 7 | 13.7 | |||
| Neurogenic | - | - | 12 | 23.5 | |||
| Other | 12 | 23.5 | |||||
BMI = body mass index; n = number of participants; % = percentage; Mean ± SD = the average value ± standard deviation; HNC = head and neck cancer.
Relative frequency (%) of answers to EAT10® items and reliability parameters of the Slovak version of EAT10®.
| Item | 0 | 1 | 2 | 3 | 4 | Test–Retest | Item-to-Total | α If Item Deleted |
|---|---|---|---|---|---|---|---|---|
| 1 | 41.2 | 13.7 | 13.7 | 3.9 | 27.5 | × | 0.66 *** | 0.93 |
| 2 | 41.2 | 5.9 | 11.8 | 15.7 | 25.5 | × | 0.69 *** | 0.93 |
| 3 | 41.2 | 15.7 | 11.8 | 15.7 | 15.7 | × | 0.68 *** | 0.93 |
| 4 | 27.5 | 19.6 | 11.8 | 13.7 | 27.5 | 0.81 *** | 0.76 *** | 0.93 |
| 5 | 33.3 | 19.6 | 15.7 | 13.7 | 17.6 | 0.91 *** | 0.73 *** | 0.94 |
| 6 | 54.9 | 21.6 | 15.7 | 3.9 | 3.9 | −0.02 | 0.56 *** | 0.94 |
| 7 | 29.4 | 17.6 | 31.4 | 11.8 | 9.8 | × | 0.74 *** | 0.93 |
| 8 | 25.5 | 19.6 | 29.4 | 9.8 | 15.7 | 0.62 *** | 0.75 *** | 0.93 |
| 9 | 43.1 | 11.8 | 17.6 | 15.7 | 11.8 | 1 *** | 0.68 *** | 0.94 |
| 10 | 31.4 | 15.7 | 19.6 | 13.7 | 19.6 | × | 0.7 *** | 0.93 |
| Overall | 0.91 *** | |||||||
| Sample size |
Relative frequency (%) of answers to EAT10® items and reliability parameters of the Slovak version of EAT10®. Values in the seventh and eighth columns are Spearman’s correlation coefficients, whereas the last column represents values of Cronbach’s alpha if the given item is removed from the dataset. Symbol × signifies items with null variability (all answers given by respondents were 0 = “no problem”). Asterisks denote the statistical significance.
Figure 1Clinical validity of EAT10®. Boxplots visualize the distribution of the total score values for (a) control and dysphagic groups of respondents and (b) dysphagic group of respondents based on the type of diagnosis. HNC = head and neck cancer; EER = extraesophageal reflux; Iatrog = iatrogenic dysphagia; Neuro = neurogenic dysphagia.
Figure 2ROC curve of the Slovak EAT10®.
Cut-off values, sensitivity, and specificity values for foreign versions of EAT10®.
| Authors | Language Version | Cut-Off | Sensitivity | Specificity |
|---|---|---|---|---|
| Belafsky et al., 2008 [ | English | 3 | − | − |
| Schindler et al., 2013 [ | Italian | 3 | − | − |
| Gonçalves et al., 2013 [ | Brazilian | 3 | 69.7% | 0.72% |
| Abu-Ghanem et al., 2016 [ | Hebrew | 3 | 92.3% | 97.3% |
| Möller et al., 2016 [ | Swedish | 3 | 98.5% | 94.1% |
| Giraldo-Cadavid et al., 2016 [ | Spanish (Colombia) | 2 | 93.6% | 36.4% |
| Printza et al., 2018 [ | Greek | 3 | − | − |
| Järvenpää et al., 2021 [ | Finnish | 3 | 0.94% | 0.96% |